首页> 外文期刊>Medicine. >Clinical Effect of Endoscopic Pneumatic Dilation for Achalasia
【24h】

Clinical Effect of Endoscopic Pneumatic Dilation for Achalasia

机译:内窥镜气管扩张术治疗失语症的临床疗效

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

Although pneumatic dilation is an accepted method for the treatment of achalasia, this therapy has high recurrence and complication rates, and prolonged follow-up studies on the parameters associated with various outcomes are rare. In this prospective 10-year follow-up study, a satisfactory therapeutic effect was achieved without serious complications. We report the therapeutic experience with pneumatic dilation, having aimed to evaluate the long-term clinical safety and efficacy of pneumatic dilation.In total, 35 consecutive patients with idiopathic achalasia who underwent pneumatic dilation were followed up at regular intervals in person or by a phone interview over a 10-year period. The mean duration of the follow-up was 43.0326.34 months (range 6-120 months). Remission was assessed by the dysphagia classification and symptom scores. Patients' clinical symptom scores were calculated before and at 6 to 36months, 37 to 60months, and >60months after therapy. The influence of the patients' age, gender, and disease duration on the therapeutic effect was analyzed.The success rate of the operation was 97.2% (35/36), without massive hemorrhaging, perforation or other serious complications. Dysphagia after the therapy was significantly eased (P<0.01). In total, 35 patients have been followed up for 6 to 36months after therapy, 21 cases for 37 to 60months, and 5 cases for >60months, and the patients' symptom scores separately decreased significantly compared with the pretherapy scores (P<0.01). For these patients, the 6 to 36months remission rate was 85.7% (30/35), the 37 to 60months rate was 61.9% (13/21), and the >60months rate was 40% (2/5). The dilation effect had no relationship to the patient's age, gender, and disease duration (P>0.05). The patients in 30 cases (85.7%) were successfully treated with a single dilation, in 4 cases (11.4%) with 2 dilations, and in 1 case (2.9%) with 3 dilations.These results suggest that endoscopic pneumatic dilation is an achalasia therapy with a good response; it is a simple and safe procedure with long-term clinical effectiveness. It is a preferred method in the treatment of achalasia.
机译:尽管气动扩张术是治疗门失弛缓症的一种公认方法,但该疗法具有较高的复发率和并发症发生率,而且很少有关于各种结局相关参数的长期随访研究。在这项为期10年的前瞻性随访研究中,获得了令人满意的治疗效果,而没有严重的并发症。我们报告了气管扩张术的治疗经验,旨在评估气管扩张术的长期临床安全性和有效性。总共,对35例接受了气管扩张术的特发性ach门失弛缓患者进行了定期随访,亲自或通过电话随访十年的访谈。随访的平均时间为43.0326.34个月(范围6-120个月)。通过吞咽困难分类和症状评分评估缓解情况。在治疗前和治疗后6至36个月,37至60个月和> 60个月计算患者的临床症状评分。分析了患者的年龄,性别和疾病持续时间对治疗效果的影响。手术成功率为97.2%(35/36),无大量出血,穿孔或其他严重并发症。治疗后吞咽困难明显缓解(P <0.01)。共有35例患者接受了治疗,随访时间为6到36个月,21例接受了37到60个月,5例接受了60个月以上的随访,患者的症状评分与治疗前相比分别显着降低(P <0.01)。对于这些患者,6至36个月的缓解率为85.7%(30/35),37至60个月的缓解率为61.9%(13/21),> 60个月的缓解率为40%(2/5)。扩张效果与患者的年龄,性别和病程无关(P> 0.05)。 30例(85.7%)患者单次扩张成功,4例(11.4%)2次扩张成功,1例(2.9%)3次扩张成功,这些结果表明内窥镜气动扩张是一种门症反应良好的疗法;这是一种简单安全的方法,具有长期的临床效果。这是治疗失弛缓症的首选方法。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号